Tuesday, January 21, 2025
spot_img

RAMSAY SANTE :repricing launch 20 01 2025

PRESS RELEASE

Paris, 20 January 2025

Ramsay Santé launches the repricing of its €1,025m TLB4 due 2031

  • On 13 August 2024, Ramsay Santé closed an Amend & Extend of its €1,650m Senior Debt facilities, including a €1,025m 7-year TLB4 priced at E+400bps.
  • On the back of currently favorable market conditions, Ramsay Santé is now looking to reprice its €1,025m TLB4. This transaction is arranged by BNP Paribas and Crédit Agricole CIB as Physical Bookrunners.
  • The completion of the transaction is subject to market conditions.

About Ramsay Santé 
Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 9,300 practitioners to treat more than 12 million patients per year in its 465 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers almost all medical and surgical specialities in three domains: Medicine, Surgery, Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and Mental Health. 

Legally, Ramsay Santé is a mission-driven company committed to constantly improving the health of all patients through innovation. Wherever it operates, the Group contributes to public health service missions and the healthcare network. Through its actions and the constant dedication of its teams, Ramsay Santé is committed to ensuring the entire patient care journey, from prevention to follow-up care. 

Every year, the group invests over 200 million euros to support the evolution and diversity of care pathways, in medical, hospital, digital, and administrative aspects. Through this commitment, our Group enhances access to care for all, commits to provides best-in-class healthcare, systematically engages in dialogue with stakeholders and strives to protect the planet to improve health. 

Facebook: https://www.facebook.com/RamsaySante 
Instagram: https://www.instagram.com/ramsaysante 
Twitter: https://twitter.com/RamsaySante 
LinkedIn: https://www.linkedin.com/company/ramsaysante 
YouTube: https://www.youtube.com/c/RamsaySante 

Code ISIN and Euronext Paris: FR0000044471 
Website:  www.ramsaysante.fr 

                               Investor / Analyst Relations                                                      Press Relations

Clément Lafaix                                                        Brigitte Cachon
Tel. +33 1 87 86 21 52                                                Tel. +33 1 87 86 22 11
[email protected]                                        [email protected]

Attachment

  • RAMSAY SANTE Press Release – Repricing launch – 20 01 2025

Powered by SlickText.com

Hot this week

Cielo Announces Shares for Debt Transactions

CALGARY, Alberta, Jan. 20, 2025 (GLOBE NEWSWIRE)...

$100 Invested In CyberArk Software 10 Years Ago Would Be Worth This Much Today

CyberArk Software CYBR has outperformed the market over the...

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

GoDaddy GDDY has outperformed the market over the past...

Trump Sets Policy Priorities: How Musk, Qualcomm CEO, Hillary Clinton, Betting Markets Reacted

Donald Trump's return to the White House came with...

Here’s How Much You Would Have Made Owning WR Berkley Stock In The Last 10 Years

WR Berkley WRB has outperformed the market over the...

Topics

Cielo Announces Shares for Debt Transactions

CALGARY, Alberta, Jan. 20, 2025 (GLOBE NEWSWIRE)...

$100 Invested In CyberArk Software 10 Years Ago Would Be Worth This Much Today

CyberArk Software CYBR has outperformed the market over the...

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

GoDaddy GDDY has outperformed the market over the past...

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Zoetis ZTS has outperformed the market over the past...

Here’s How Much $1000 Invested In Tapestry 5 Years Ago Would Be Worth Today

Tapestry TPR has outperformed the market over the past...

Here’s How Much $1000 Invested In Chemed 20 Years Ago Would Be Worth Today

Chemed CHE has outperformed the market over the past...
spot_img

Related Articles

Popular Categories

spot_img